Oral Anticoagulants vs. Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Verdict is in

By van Walraven C.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 374-378

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of Warfarin versus Aspirin for the Prevention of Recurrent Stroke or Death: Subgroup Analyses from the Warfarin-Aspirin Recurrent Stroke Study

By  

Cerebrovascular Diseases, Vol. 22, Iss. 1, 2006-04 ,pp. : 4-12

Karger

Access to resources Recommend Favorite

The Japanese Aggrenox (Extended-Release Dipyridamole plus Aspirin) Stroke Prevention versus Aspirin Programme (JASAP) Study: A Randomized, Double-Blind, Controlled Trial

By  

Cerebrovascular Diseases, Vol. 31, Iss. 6, 2011-04 ,pp. : 601-613

Karger

Access to resources Recommend Favorite

Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study

By Athyros Vasilios G.   Mikhailidis Dimitri P.   Papageorgiou Athanasios A.   Bouloukos Vasilios I.   Pehlivanidis Anthimos N.   Symeonidis Athanasios N.   Kakafika Anna I.   Daskalopoulou Stella S.   Elisaf Moses  

Platelets, Vol. 16, Iss. 2, 2005-03 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study

By  

Cerebrovascular Diseases, Vol. 27, Iss. 5, 2009-04 ,pp. : 509-518

Karger

Access to resources Recommend Favorite